INHIBRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.14 USD | -0.15% |
|
-0.93% | -10.16% |
| 05-24 | Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi | MT |
| 05-09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INHIBRX, INC. | Bio Therapeutic Drugs | -0.15% | -0.93% | -10.16% | +41.31% | - | 1.79B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- INBX Stock
- Charts Inhibrx, Inc.
- Comparison Chart
